Missing Data and Censoring in the Analysis of Progression-Free Survival in Oncology Clinical Trials
โ Scribed by Denne, J. S.; Stone, A. M.; Bailey-Iacona, R.; Chen, T.-T.
- Book ID
- 121715146
- Publisher
- Taylor and Francis Group
- Year
- 2013
- Tongue
- English
- Weight
- 314 KB
- Volume
- 23
- Category
- Article
- ISSN
- 1054-3406
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Incorporation of quality of life (QOL) investigation into Eastern Cooperative Oncology Group (ECOG) multi-centre clinical trials has led to innovative strategies for protocol design and high quality data collection. A scientific advisory committee reviews protocol design components, measurement sele
We summarize issues that arise when considering quality of life (QOL) data in cancer clinical trials, especially those related to missing data. We describe different types of missing data mechanisms, and discuss ways of assessing and testing missing data mechanisms. A section on presentation of stud
Goetghebeur and Ryan proposed a method for proportional hazards analyses of competing risks failuretime data when the failure type is missing for some cases. This paper evaluates the properties of the method using data from a clinical trial in Hodgkin's disease. We generated several patterns of miss